FR2389597B1 - - Google Patents

Info

Publication number
FR2389597B1
FR2389597B1 FR7813202A FR7813202A FR2389597B1 FR 2389597 B1 FR2389597 B1 FR 2389597B1 FR 7813202 A FR7813202 A FR 7813202A FR 7813202 A FR7813202 A FR 7813202A FR 2389597 B1 FR2389597 B1 FR 2389597B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7813202A
Other versions
FR2389597A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Continental Pharma Inc
Original Assignee
Continental Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU77237A external-priority patent/LU77237A1/xx
Priority claimed from LU77236A external-priority patent/LU77236A1/xx
Application filed by Continental Pharma Inc filed Critical Continental Pharma Inc
Publication of FR2389597A1 publication Critical patent/FR2389597A1/fr
Application granted granted Critical
Publication of FR2389597B1 publication Critical patent/FR2389597B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
FR7813202A 1977-05-03 1978-05-03 Expired FR2389597B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU77237A LU77237A1 (fr) 1977-05-03 1977-05-03
LU77236A LU77236A1 (fr) 1977-05-03 1977-05-03

Publications (2)

Publication Number Publication Date
FR2389597A1 FR2389597A1 (fr) 1978-12-01
FR2389597B1 true FR2389597B1 (fr) 1983-08-19

Family

ID=26640226

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7813202A Expired FR2389597B1 (fr) 1977-05-03 1978-05-03

Country Status (21)

Country Link
US (1) US4474977A (fr)
JP (1) JPS5940140B2 (fr)
AR (1) AR224499A1 (fr)
AT (1) AT358020B (fr)
CA (1) CA1118438A (fr)
CH (1) CH635570A5 (fr)
DE (1) DE2817494A1 (fr)
DK (1) DK189878A (fr)
ES (1) ES469843A1 (fr)
FI (1) FI781347A (fr)
FR (1) FR2389597B1 (fr)
GR (1) GR64990B (fr)
IE (1) IE47194B1 (fr)
IL (1) IL54608A (fr)
IT (1) IT1113140B (fr)
MX (1) MX5160E (fr)
NL (1) NL7804621A (fr)
NO (1) NO146057C (fr)
PT (1) PT67969B (fr)
SE (1) SE7804897L (fr)
YU (1) YU106178A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103830A3 (fr) * 1982-09-22 1985-07-31 Bayer Ag Dérivés de phényléthylamine comme stimulateurs de croissance
NZ523554A (en) * 2000-07-13 2004-12-24 Sankyo Co Amino alcohol derivatives
US6399828B1 (en) * 2001-10-29 2002-06-04 Boehringer Ingelheim Chemicals, Inc. Preparation of amphetamines from phenylpropanolamines
WO2004007456A1 (fr) * 2002-07-17 2004-01-22 Lek Pharmaceuticals D.D. Nouveaux derives d'amines pyridylethanol (phenylethyl) utiles comme inhibiteurs de la biosynthese du cholesterol, leurs procedes de preparation et compositions pharmaceutiques les contenant
EP1814841A4 (fr) * 2004-10-29 2011-03-16 Musc Found For Res Dev Ceramides et ligands de signalisation de l'apoptose
GB0624757D0 (en) * 2006-12-12 2007-01-17 Sosei R & D Ltd Novel compounds
RU2011117722A (ru) 2008-11-06 2012-12-20 Фонд Медицинского Университета Южной Каролины по развитию научных исследований Лизосомотропные ингибиторы кислой церамидазы
CN101759665B (zh) * 2008-12-23 2012-03-28 江苏恩华药业股份有限公司 取代苯基哌嗪芳烷醇衍生物及其在制备镇痛药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1799110A (en) * 1928-07-21 1931-03-31 Lilly Co Eli Process of producing ephedrine and structurally-similar compounds and products of such process
NL112967C (fr) 1961-05-09
DE1249881B (de) * 1962-10-18 1967-09-14 Aktiebolaget Hassle Apotekare Paul Nordstrome Fabriker Göteborg (Schweden) Verfahren zur Herstellung von Phenylathanolammen und deren Salzen
AT244932B (de) 1963-06-04 1966-02-10 Haessle Ab Verfahren zur Herstellung von neuen Phenyläthanolaminen und ihren Salzen
AT252214B (de) * 1963-10-09 1967-02-10 Bayer Ag Verfahren zur Herstellung von neuen D(-)-N-Akyl-1-phenyl-2-aminoäthanolen und/oder deren Salzen
DE1593837A1 (de) 1967-06-29 1970-10-29 Degussa Verfahren zur Herstellung von neuen Aminoketonen
US3714229A (en) * 1969-07-10 1973-01-30 Merck & Co Inc ESTERS OF 3-HYDROXY- alpha -(1-AMINOETHYL)-BENZYL ALCOHOL
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
US4018825A (en) * 1972-07-27 1977-04-19 Warner-Lambert Company 5-Hydroxy-α-(substituted aminomethyl)-m-xylene-α,α'-diols
US3809714A (en) * 1972-08-31 1974-05-07 Interx Research Corp Novel ester of ((methylamino)methyl) benzyl alcohol
GB1390748A (en) * 1973-04-09 1975-04-16 Continental Pharma Alkyl and cycloalkylthiophenylalkylaminoalkanols their salts and the preparation thereof
US4009179A (en) * 1975-10-15 1977-02-22 E. I. Du Pont De Nemours And Company Di- and tri-substituted oxazolidin-2-one oximes

Also Published As

Publication number Publication date
ES469843A1 (es) 1979-09-16
CA1118438A (fr) 1982-02-16
JPS53141230A (en) 1978-12-08
NL7804621A (nl) 1978-11-07
PT67969B (fr) 1979-11-14
YU106178A (en) 1983-01-21
CH635570A5 (fr) 1983-04-15
IE780867L (en) 1978-11-03
JPS5940140B2 (ja) 1984-09-28
IT1113140B (it) 1986-01-20
NO781554L (no) 1978-11-06
FR2389597A1 (fr) 1978-12-01
GR64990B (en) 1980-06-11
IL54608A (en) 1984-01-31
US4474977A (en) 1984-10-02
AR224499A1 (es) 1981-12-15
NO146057C (no) 1982-07-21
DK189878A (da) 1978-11-04
PT67969A (fr) 1978-05-01
AT358020B (de) 1980-08-11
NO146057B (no) 1982-04-13
ATA317978A (de) 1980-01-15
SE7804897L (sv) 1978-11-04
IE47194B1 (en) 1984-01-11
IL54608A0 (en) 1978-07-31
DE2817494A1 (de) 1978-11-09
FI781347A (fi) 1978-11-04
MX5160E (es) 1983-04-11
IT7822985A0 (it) 1978-05-03

Similar Documents

Publication Publication Date Title
FR2377162B1 (fr)
DE2839651C2 (fr)
DK11177A (fr)
DE2811480C2 (fr)
FR2347682B1 (fr)
DE2847822C2 (fr)
FR2389597B1 (fr)
DE2733778C2 (fr)
DE2740987B2 (fr)
FR2376717B1 (fr)
AU3353778A (fr)
DE2735657C2 (fr)
DE2757184C2 (fr)
FI53648B (fr)
AU495917B2 (fr)
DK78677A (fr)
AU71461S (fr)
DE7716473U1 (fr)
DK522877A (fr)
BG23462A1 (fr)
BE866391A (fr)
BE873002A (fr)
BE871991A (fr)
BG23438A1 (fr)
BG25829A1 (fr)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse